NDC Package 70257-414-87 Lyvispah

Baclofen Granule Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70257-414-87
Package Description:
90 PACKET in 1 BOTTLE, UNIT-DOSE / 1 GRANULE in 1 PACKET
Product Code:
Proprietary Name:
Lyvispah
Non-Proprietary Name:
Baclofen
Substance Name:
Baclofen
Usage Information:
Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.
11-Digit NDC Billing Format:
70257041487
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
90 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2586589 - baclofen 10 MG Oral Granules
  • RxCUI: 2586595 - LYVISPAH 10 MG Oral Granules
  • RxCUI: 2586595 - baclofen 10 MG Oral Granules [Lyvispah]
  • RxCUI: 2586595 - Lyvispah 10 MG Oral Granules
  • RxCUI: 2586596 - baclofen 20 MG Oral Granules
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Saol Therapeutics Inc
    Dosage Form:
    Granule - A small particle or grain.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA215422
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    11-22-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70257-414-87?

    The NDC Packaged Code 70257-414-87 is assigned to a package of 90 packet in 1 bottle, unit-dose / 1 granule in 1 packet of Lyvispah, a human prescription drug labeled by Saol Therapeutics Inc. The product's dosage form is granule and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package.

    Is NDC 70257-414 included in the NDC Directory?

    Yes, Lyvispah with product code 70257-414 is active and included in the NDC Directory. The product was first marketed by Saol Therapeutics Inc on November 22, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 70257-414-87?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 90.

    What is the 11-digit format for NDC 70257-414-87?

    The 11-digit format is 70257041487. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270257-414-875-4-270257-0414-87